Clinical Trial Result Information

Protocol number
WA20496

Title of Study
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have An Inadequate Response to Methotrexate

Sponsor
Hoffmann-La Roche

Company division
Pharmaceutical

Product name
ocrelizumab

Therapeutic area
Rheumatoid Arthritis

Clinical study summary
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.

Phase of development
III

Date of report
To be Published

Click here for the protocol registry listing of this trial.